000 | 01717 a2200529 4500 | ||
---|---|---|---|
005 | 20250513201426.0 | ||
264 | 0 | _c20000121 | |
008 | 200001s 0 0 eng d | ||
022 | _a0003-9942 | ||
024 | 7 |
_a10.1001/archneur.57.1.94 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGreenberg, S M | |
245 | 0 | 0 |
_aDonepezil therapy in clinical practice: a randomized crossover study. _h[electronic resource] |
260 |
_bArchives of neurology _cJan 2000 |
||
300 |
_a94-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDonepezil |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndans _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 |
_aNootropic Agents _xadministration & dosage |
650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTennis, M K | |
700 | 1 | _aBrown, L B | |
700 | 1 | _aGomez-Isla, T | |
700 | 1 | _aHayden, D L | |
700 | 1 | _aSchoenfeld, D A | |
700 | 1 | _aWalsh, K L | |
700 | 1 | _aCorwin, C | |
700 | 1 | _aDaffner, K R | |
700 | 1 | _aFriedman, P | |
700 | 1 | _aMeadows, M E | |
700 | 1 | _aSperling, R A | |
700 | 1 | _aGrowdon, J H | |
773 | 0 |
_tArchives of neurology _gvol. 57 _gno. 1 _gp. 94-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archneur.57.1.94 _zAvailable from publisher's website |
999 |
_c10589794 _d10589794 |